1	Receiving HAART defined as at least two nucleoside reverse transcriptase inhibitors plus at least one protease inhibitor or non-nucleoside reverse transcriptase inhibitor without changes to the regimen within 24 weeks of study entry|protease inhibitor[102,120]||||||||||8827|8827|protease inhibitor
1	Receiving HAART defined as at least two nucleoside reverse transcriptase inhibitors plus at least one protease inhibitor or non-nucleoside reverse transcriptase inhibitor without changes to the regimen within 24 weeks of study entry|nucleoside reverse transcriptase inhibitors[40,83]||||||||||987262|987262|nucleoside reverse transcriptase inhibitors
1	Receiving HAART defined as at least two nucleoside reverse transcriptase inhibitors plus at least one protease inhibitor or non-nucleoside reverse transcriptase inhibitor without changes to the regimen within 24 weeks of study entry|reverse transcriptase inhibitor[139,170]|||||||24 weeks[209,217]|||82143|82143|reverse transcriptase inhibitor
